More Globe Newswire

View Older Stories View Newer Stories

Oct 30, 2025 08:00AM Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call
Oct 30, 2025 08:00AM New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual
Oct 30, 2025 08:00AM Arcutis Launches ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5
Oct 30, 2025 08:00AM Ultragenyx Announces First Patient Dosed in Aurora Study Evaluating GTX-102 in Additional Angelman Syndrome Genotypes and Age Groups
Oct 30, 2025 08:00AM Rick Sherlund, Wall Street Legend, joins in Partnership with Wedbush Tech Investment Banking
Oct 30, 2025 08:00AM Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care
Oct 30, 2025 08:00AM Biomea Fusion to Present Poster Presentations at ObesityWeek®2025
Oct 30, 2025 08:00AM SunPower Executes Major Sales Force Expansion Following Sunder Merger
Oct 30, 2025 08:00AM Workhorse Reminds Shareholders to Vote Today FOR All Proposals
Oct 30, 2025 08:00AM Monster Beverage to Report Financial Results for 2025 Third Quarter on November 6, 2025
Oct 30, 2025 08:00AM Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus
Oct 30, 2025 08:00AM ZenaTech to Highlight Drone as a Service, AI Drone Solutions, and US Defense Initiatives at Three Upcoming Investor Conferences
Oct 30, 2025 08:00AM Rumble Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
Oct 30, 2025 08:00AM Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting
Oct 30, 2025 08:00AM Kinetic Teams Up With eero to Deliver Next-Gen Secure Home Wi-Fi
Oct 30, 2025 08:00AM Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
Oct 30, 2025 08:00AM Solid Biosciences to Participate at Upcoming Investor Conferences
Oct 30, 2025 08:00AM Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025
Oct 30, 2025 08:00AM 23andMe Research Institute Appoints Privacy Advisory Board
Oct 30, 2025 08:00AM Barry Hytinen Appointed to ABM’s Board of Directors
Oct 30, 2025 08:00AM Edible Garden Receives Preliminary Approval to Sell Up to $3.35 Million in Tax Credits Through NJEDA Program
Oct 30, 2025 08:00AM UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025
Oct 30, 2025 08:00AM Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
Oct 30, 2025 08:00AM T-knife Therapeutics Announces Four Upcoming Data Presentations on PRAME-Targeted TK-6302 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oct 30, 2025 08:00AM Kojamo plc’s Interim Report 1 January–30 September 2025
Oct 30, 2025 08:00AM Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025
Oct 30, 2025 08:00AM Harvia will publish its Interim report for January–September 2025 on Thursday, 6 November 2025 at around 9:00 a.m. EET
Oct 30, 2025 08:00AM Municipality Finance will redeem early notes issued under its MTN programme
Oct 30, 2025 08:00AM Evaxion raises $7.2 million, extending cash runway to second half of 2027
Oct 30, 2025 08:00AM OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
Oct 30, 2025 07:55AM Ramsey Theory Group CEO Dan Herbatschek Urges Enterprises to Prepare for Post-SaaS Era as AI Agents Reshape Software Delivery and Licensing Models
Oct 30, 2025 07:55AM Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
Oct 30, 2025 07:40AM CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Rα Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
Oct 30, 2025 07:30AM First National Corporation Reports Record Third Quarter 2025 Earnings
Oct 30, 2025 07:30AM Lancaster Resources LiDAR Results and Field Trip Data from Lake Cargelligo Gold Project
Oct 30, 2025 07:30AM Dynacor Begins Plant Shipments to Senegal; Continues Ecuador Integration
Oct 30, 2025 07:30AM Knight Therapeutics Announces Approval and Launch of MINJUVI® (tafasitamab) in Argentina
Oct 30, 2025 07:30AM DT Midstream Reports Strong Third Quarter 2025 Results; Raises Adjusted EBITDA Guidance
Oct 30, 2025 07:30AM Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
Oct 30, 2025 07:30AM Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call
Oct 30, 2025 07:30AM FG Nexus Announces Listing on Deutsche Börse in Germany U.S. NASDAQ Ticker is FGNX and German Borse Ticker is LU51
Oct 30, 2025 07:30AM Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
Oct 30, 2025 07:30AM Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
Oct 30, 2025 07:30AM Digi Power X to Announce 2025 Q3 Financial Results on November 13th
Oct 30, 2025 07:30AM Laureate Education Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2025
Oct 30, 2025 07:30AM Brixton Metals Makes Copper-Gold Porphyry Discovery at the Catalyst Target on its Thorn Project
Oct 30, 2025 07:30AM Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches
Oct 30, 2025 07:30AM SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results
Oct 30, 2025 07:30AM Saia Reports Third Quarter Results
Oct 30, 2025 07:30AM Applied Materials to Report Fourth Quarter and Fiscal 2025 Results on Nov. 13, 2025
View Newer Stories View Older Stories